Evaluation of a Monofocal Intraocular Lens

Inclusion Criteria:

1. Be at least 50 years of age or older, male or female, of any race or ethnicity.

2. Presenting for uncomplicated bilateral cataract surgery for age-related cataract.

3. Planned bilateral cataract extraction with posterior chamber IOL implantation, viaphacoemulsification with or without femtosecond laser assisted cataract surgery (FLACS).

4. Bilateral implantation of a CT LUCIA 621P IOL with a dioptric power between +10.00 Dand +30.00 D and a target postoperative refraction of emmetropia (0.00 ±0.50 D).

5. Clear intraocular media other than cataract (i.e. no hyphema, vitreous hemorrhage)

6. No visual acuity limiting pathologies other than cataract. Best correctedpostoperative visual acuity potential of 20/25 or better in both eyes as estimatedby potential acuity meter or surgeon estimation.

7. Provide written informed consent and a signed HIPPA form.

8. Availability, willingness, ability, and sufficient cognitive awareness to complywith study examination procedures and the schedule for study visits and evaluations.

Exclusion Criteria:

1. Corneal Astigmatism of >1.0 D.

2. Planned monocular cataract extraction.

3. Visual field loss which has an impact on visual acuity.

4. Subjects with intraoperative surgical complications in whom a CT LUCIA 621P IOLcannot be implanted.

5. History of acute or chronic disease, pathology, illness, or ocular trauma thatwould, in the surgeon's opinion, confound results (e.g., corneal pathology,keratoconus, strabismus, uncontrolled glaucoma)

6. History of Glaucoma, macular degeneration, cystoid macular edema, proliferativediabetic retinopathy, amblyopia, etc.

7. Previous intraocular or corneal surgery, including all forms of refractive surgerythat might confound the outcome of the investigation or increase the risk to thesubject

8. Previous anterior or posterior chamber surgery other than peripheral retinal barrierlaser, SLT/ALT (e.g., vitrectomy, laser iridotomy)

9. Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupilsthat do not dilate under mesopic/scotopic conditions).

10. Capsular or zonular abnormalities or other conditions that increase the risk ofzonular rupture during cataract extraction procedure and/or may affect thepostoperative centration or tilt of the lens

11. Use of a systemic or ocular medication that might affect vision and confound theoutcome or increase the risk to the subject in the opinion of the investigator suchas tamsulosin hydrochloride (Flomax) or other medications with similar side effects (floppy iris syndrome)

12. Cycloplegic pupil diameter <6.0 mm or the presence of ocular implants that limitpupil diameter (malyugin rings; iris prosthesis).

13. Usage of contact lenses during study participation

14. Pregnant, lactating during the course of the investigation, or has another conditionwith associated fluctuation of hormones that could lead to refractive changes

15. Presence or history or any other condition or finding that, in the investigator'sopinion, makes the subject unsuitable as a candidate for study participation, mayincrease the operative risk or may confound the outcome of the study.